“Going Full TILt: challenges, successes, and coordination with administering TIL therapy” is an upcoming “Rx-cited: Clinical Conundrums” roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force, scheduled for Wednesday, December 17, 2025, from 2:00–3:00 PM CST.

The session is designed to be an informal Q&A discussion focusing on the challenges, key points, and future directions associated with offering Tumor Infiltrating Lymphocyte (TIL) therapy, providing a space for both members and non-members working in transplantation and cellular therapy to connect and share insights on these latest advancements.

Register.